FR3534M - New isoquinoline that can be used in therapy, in particular as an antitussive agent. - Google Patents

New isoquinoline that can be used in therapy, in particular as an antitussive agent.

Info

Publication number
FR3534M
FR3534M FR975038A FR975038A FR3534M FR 3534 M FR3534 M FR 3534M FR 975038 A FR975038 A FR 975038A FR 975038 A FR975038 A FR 975038A FR 3534 M FR3534 M FR 3534M
Authority
FR
France
Prior art keywords
therapy
antitussive agent
new isoquinoline
isoquinoline
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR975038A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH220563A external-priority patent/CH449013A/en
Priority claimed from FR964435A external-priority patent/FR1389737A/en
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR3534M publication Critical patent/FR3534M/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR975038A 1963-02-21 1964-05-20 New isoquinoline that can be used in therapy, in particular as an antitussive agent. Active FR3534M (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH220563A CH449013A (en) 1963-02-21 1963-02-21 Process for the preparation of new isoquinoline compounds
CH67264 1964-01-21
CH67164 1964-01-21
FR964435A FR1389737A (en) 1963-02-21 1964-02-20 Process for the preparation of a novel isoquinoline, namely 4-methyl-1-morpholino-3-morpholinomethyl-isoquinoline, and its salts

Publications (1)

Publication Number Publication Date
FR3534M true FR3534M (en) 1965-09-13

Family

ID=27172297

Family Applications (2)

Application Number Title Priority Date Filing Date
FR975038A Active FR3534M (en) 1963-02-21 1964-05-20 New isoquinoline that can be used in therapy, in particular as an antitussive agent.
FR975039A Active FR3782M (en) 1963-02-21 1964-05-20 New isoquinoline usable in therapy, in particular as a beaker.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR975039A Active FR3782M (en) 1963-02-21 1964-05-20 New isoquinoline usable in therapy, in particular as a beaker.

Country Status (4)

Country Link
BE (2) BE644126A (en)
FR (2) FR3534M (en)
GB (2) GB1021526A (en)
NL (2) NL6401592A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7824661B2 (en) 2002-03-11 2010-11-02 Molecular Insight Pharmaceuticals, Inc. Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
ES2559764T3 (en) 2002-03-11 2016-02-15 Molecular Insight Pharmaceuticals, Inc. Technetium dipyridine complexes, and methods of use thereof
US8685369B2 (en) 2004-02-12 2014-04-01 Molecular Insight Pharmaceuticals, Inc. Technetium- and rhenium-bis (heteroaryl) complexes, and methods of use thereof

Also Published As

Publication number Publication date
BE644126A (en) 1964-08-20
NL6401593A (en) 1964-08-24
GB1021525A (en) 1966-03-02
FR3782M (en) 1965-12-27
NL6401592A (en) 1964-08-24
BE644127A (en) 1964-08-20
GB1021526A (en) 1966-03-02

Similar Documents

Publication Publication Date Title
FR3692M (en) New amino acid that can be used in therapy, in particular as a muscular spasmolytic and hypnotic.
FR3290M (en) New amines which can be used in therapy, in particular as inhibitors of mono-aminoxidase.
AT251427B (en) Capsule work, in particular curve capsule work
FR3439M (en) New quinazoline which can be used in therapy, in particular as an analgesic.
FR3818M (en) New imidazole which can be used in therapy, in particular as an antischistosomal and antiamoebic agent.
OA00772A (en) Dermatology composition.
FR3734M (en) New piperazine which can be used in therapy, in particular as a hypotensive agent.
FR3534M (en) New isoquinoline that can be used in therapy, in particular as an antitussive agent.
FR3309M (en) New piperazine which can be used in therapy, in particular as an antiphlogistic.
FR2691M (en) New a-nor-b-homo-steroids which can be used in therapy, in particular as gestagenes.
FR1898M (en) New substance usable in therapy.
FR3864M (en) New piperazines which can be used in therapy, in particular as hypotensive agents.
FR3805M (en) New & delta <4> -7α-methyl-17β-hydroxy-19-nor-androstene-3-one usable in therapy.
FR3504M (en) New phthalazinium compound that can be used in therapy, in particular as a vermicide.
FR2617M (en) New drug which can be used in particular in cancer therapy.
DK107933C (en) Wash-resistant finishing agent.
OA00988A (en) Scaffolding.
FR3416M (en) New amino acid that can be used in therapy, in particular as a muscular spasmolytic and hypnotic.
FR2331M (en) New 2,3-dihydro-benzofuran which can be used in therapy, in particular as an antihypertensive agent.
FR2714M (en) New sulfonamide which can be used in therapy, in particular as a chemotherapeutic agent.
FR2745M (en) New sulfonamide which can be used in therapy, in particular as a chemotherapeutic agent.
FR3248M (en) New sulfonamide which can be used in therapy, in particular as a chemotherapeutic agent.
FR3015M (en) New a-nor-b-homo-steroids which can be used in therapy, in particular as anabolic agents.
FR2715M (en) New sulfonamides which can be used in therapy, in particular as chemotherapeutic agents.
FR2408M (en) New basic ketones that can be used in therapy, in particular as stimulants.